- Home
- Companies
- north america
- advanced whole exome sequencing
Show results for
Refine by
Advanced Whole Exome Sequencing Suppliers In North America
48 companies found
based inMemphis, TENNESSEE (USA)
Meridian Bioscience is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
FUSION GENOMICS ONETest platform offers a complete 12 hours “Benchtop to Desktop” solution for next generation sequencing based diagnostic testing of infectious diseases. The ONETest platform comprises our patent pending and proprietary ...
based inLund, SWEDEN
Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...
Qlucore's clinical diagnostics solutions for multi-omics companion and precision diagnostics include AI-powered, disease-specific machine learning based classifier models and are combined with patient-friendly visualizations in a an easy-to-use ...
based inCambridge, MASSACHUSETTS (USA)
Arc Bio is revolutionizing microbial detection with proprietary, turnkey metagenomic Next-Generation Sequencing (mNGS) workflow and software solutions for fast, precise, and cost-effective analyses. Arc Bio is revolutionizing microbial detection by ...
based inFriendswood, TEXAS (USA)
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and ...
Our DecisionDx-UMSeq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor genes may someday help guide treatment decisions. ...
based inSeville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a ...
based inCoralville, IOWA (USA)
A champion of life sciences research for more than 30 years, IDT develops and manufactures nucleic acid products that support the life sciences industry. Areas of focus include academic and commercial research, agriculture, medical diagnostics, ...
based inSunnyvale, CALIFORNIA (USA)
Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to ...
based inVienna, AUSTRIA
Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by ...
The SPLIT RNA Extraction Kit enables a fast and highly efficient extraction of RNA that is free of genomic DNA contamination. The RNA can be recovered as total RNA or split into two fractions, large RNA and small RNA, facilitating the analysis of ...
based inHuntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
Kailos Iota combines TargetRich, our foundational genetic enrichment technology, with next-generation sequencing and statistical machine learning that results in a highly specific cancer assay of multiple solid tumors at all stages. The Iota assay ...
based inAnn Arbor, MICHIGAN (USA)
Gene Codes Corporation is an international software firm specializing in bioinformatics software for DNA sequence analysis. Gene Codes' scientist-friendly software tools hold the dominant share in the DNA sequencing sector and are unrivaled in ...
Sequencher empowers the benchtop scientist by bringing the latest peer-reviewed NGS algorithms out of the command line and into an intuitive point and click interface. Whether performing reference-guided alignments, de novo assembly, variant ...
based inMelbourn, UNITED KINGDOM
SPT Labtech is a team of exceptionally skilled scientists, engineers and business innovators. We have one overarching mission: to work together to accelerate life science research. Through our innovative solutions and state-of-the-art tools, we ...
based inPhiladelphia, PENNSYLVANIA (USA)
With extensive experience optimising processes for analytical, production and R&D laboratories across multiple industries and regulatory environments, we provide consistent, quality informatics solutions. We operate on a truly global basis, serving ...
Specimen to report in a single day with a hands-off, automated workflow. The Ion Torrent Genexus System is the first turnkey next-generation sequencing (NGS) solution that automates the specimen-to-report workflow and delivers results in a single ...
based inGermantown, MARYLAND (USA)
Based in Germantown, MD, CosmosID®’s CLIA-certified, GCP-compliant laboratory provides the microbiome field with access to standardized and validated metagenomics solutions so that industry, academia & clinicians can unlock the microbiome with ...
based inPalo Alto, CALIFORNIA (USA)
SBI is a small biotech company that’s delivered innovative products and services for molecular and cell biology research since January 2004, when we sold our first lentivectors and pPACK lentivirus packaging systems. We focus on being the first ...
based inGuilford, CONNECTICUT (USA)
Quantum-Si is an innovative life sciences company with the mission of transforming single-molecule analysis and democratizing its use by providing researchers and clinicians access to the proteome, the set of proteins expressed within a cell. We ...
based inLondon, UNITED KINGDOM
PCR Biosystems was founded in 2012 by two PCR experts who believed scientists deserved better performance and value from their PCR products. We wanted to do things differently. We’ve developed a range of PCR reagents that maximise yield and ...
The NGSBIO Library Quant Kit contains all the components required for accurate and sensitive quantification of libraries prepared for Illumina NGS systems. The kit uses qPCR to specifically quantify adapter-ligated DNA molecules, ensuring optimal ...
based inChicago, ILLINOIS (USA)
Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we ...
Tempus xE (version 2) is a whole exome next-generation sequencing assay that analyzes the entire coding region (exome) of the patient’s genome, combined with whole transcriptome RNA sequencing. Clinical sequencing is performed to 500x depth of ...
based inNew Haven, CONNECTICUT (USA)
AtlasXomics offers the first comprehensive spatial epigenome technology; AtlasXomics, a 2020 Yale spin-out, is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases. This ...
The DBiT-seq discovery platform combines microfluidics with next generation sequencing. The process starts by adding multi-omic probes (e.g., for mRNA, genomic DNA, or proteins) directly to a tissue section. Sequentially and orthogonally applied ...
